Labshake search
Citations for Tocris :
601 - 650 of 1604 citations for 6 CHLORO 2 3 4 4A 9 9A HEXAHYDRO 1H CARBAZOLE 1 CARBOXAMIDE since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2021Quote: ... d-amphetamine sulphate (2 mg/kg, Tocris), JZL184 (8 mg/kg ...
-
bioRxiv - Cell Biology 2022Quote: ... and 2 μM A-83 (Tocris, 692), in non-treated polystyrene plates for 7 days with a daily medium change ...
-
bioRxiv - Developmental Biology 2020Quote: ... 2 µM CHIR99021 (Tocris, cat no: 4423), 0.5 µM A83-01 (Tocris ...
-
bioRxiv - Neuroscience 2020Quote: ... and 2 QX-314 bromide (Tocris Bioscience). Theta-glass pipettes (Warner Instruments ...
-
bioRxiv - Neuroscience 2020Quote: ... Y27632 dihydrochloride (Tocris Catalog #129830-23-2), to ensure the survival of singly dissociated stem cells ...
-
bioRxiv - Cell Biology 2021Quote: ... or NVP-2 (Tocris Bioscience, in DMSO) at doses/times indicated in the figure legends ...
-
bioRxiv - Developmental Biology 2022Quote: ... supplemented either with 2 μM Gö6983 (Tocris), 1 μM PD0325901 ...
-
bioRxiv - Cell Biology 2019Quote: ... and 2 μM GSK 269962 (Tocris 4009). Details of treatment times are described in figure legends ...
-
bioRxiv - Neuroscience 2019Quote: ... arachidonyl-2’-chloroethylamide (ACEA, #1319, Tocris, USA), WIN 55,212-2 mesylate (WIN ...
-
bioRxiv - Neuroscience 2020Quote: ... WIN 55,212-2 was purchased from Tocris Bioscience (Bristol ...
-
bioRxiv - Neuroscience 2021Quote: ... 2 µM GSK3 inhibitor IX (BIO) (Tocris), and 20 µM SB431542 (Tocris) ...
-
bioRxiv - Bioengineering 2022Quote: ... the Wnt inhibitor IWP2 (2□uM, TOCRIS) and rhVEGF (10□ng/mL ...
-
bioRxiv - Neuroscience 2022Quote: ... ascorbic acid (2 mM, Tocris Bioscience, 4055). Medium was passed through a 0.22-µm filter ...
-
bioRxiv - Neuroscience 2023Quote: ... 2 mM of A83-01 (Tocris, 2939), and kept shaking at 95 rpm for 7 days ...
-
bioRxiv - Cancer Biology 2022Quote: ... 2 μM A83-01 (2939; Tocris Bioscience), 10 ng/mL murine EGF (PMG8043 ...
-
bioRxiv - Developmental Biology 2022Quote: ... 2 μM Dimethinedene maleate (DiM) (Tocris, 1425) and 2 μM Minocycline hydrochloride (MiH ...
-
bioRxiv - Cancer Biology 2023Quote: ... 10uM IWP-2 (Tocris, Cat. No. 3533) dissolved in DMSO ...
-
bioRxiv - Biophysics 2023Quote: ... 10 μM of CRANAD-2 (4803, Tocris), and 5 nM of Cy3B hydrolyzed from Cy3B-NHS ester (PA63101 ...
-
bioRxiv - Developmental Biology 2023Quote: ... 8nM β-estradiol (50-28-2, Tocris) and 200ng/mL progesterone (P0130 ...
-
bioRxiv - Cell Biology 2022Quote: ... 10 μM Y27632 (129830-38-2, Tocris), 10 nM of Rho Activator II CN03 (Cytoskeleton ...
-
bioRxiv - Cell Biology 2022Quote: ... and 2 μM A-83 (Tocris, 692). After 7 days ...
-
bioRxiv - Bioengineering 2023Quote: ... or 2 mg of VP (Tocris Bioscience) was dissolved in 1 mL of DCM containing PLGA ...
-
bioRxiv - Neuroscience 2024Quote: ... and 2 QX-314 bromide (Tocris Bioscience). Theta-glass pipettes (Warner Instruments ...
-
bioRxiv - Neuroscience 2023Quote: ... SGC-CK-2 was purchased from Tocris. All additional chemicals were purchased from Sigma-Aldrich.
-
bioRxiv - Biophysics 2023Quote: ... and 2 µM ZK 20075 (Tocris, 2345) and moved into a 30 ˚C ...
-
bioRxiv - Neuroscience 2023Quote: ... 2 μM XAV939 (Tocris Bioscience, Bristol, UK), and 3 μg/ml doxycycline (Sigma) ...
-
bioRxiv - Molecular Biology 2024Quote: ... TLR1/2 was stimulated with Pam3CSK4 (Tocris). Mock stimulations were conducted with vehicle only ...
-
bioRxiv - Neuroscience 2020Quote: ... slices were equilibrated for 10 minutes while being continuously superfused at room temperature with oxygenated aCSF at 1-2 ml/min containing picrotoxin (50 μM, Tocris Bioscience, MO, USA) to block GABAA receptor-mediated inhibitory responses.
-
bioRxiv - Neuroscience 2024Quote: ... a third group of animals were treated as those in group 2 with the addition of CB1 receptor antagonist AM251 (1 µM) (Tocris Bioscience, Bristol, UK). After 8 DIV ...
-
bioRxiv - Neuroscience 2021Quote: ... 20 μM of 2,3-dihydroxy 6-nitro-7-sulfamoyl-benzoquinoxaline-2,3-dione (NBQX, 1044, Tocris Bioscience, UK), 25 μM of d-(-)-2-amino-5-phosphonopentanoic acid (D-AP5 ...
-
bioRxiv - Neuroscience 2019Quote: ... Cells were split 12–30 h after transfection and plated on glass coverslips in the presence of 50 μM NBQX (2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide; Tocris Bioscience) to avoid AMPAR-mediated toxicity ...
-
bioRxiv - Neuroscience 2023Quote: ... to block Na channels or 6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX, 10 µM, Tocris, Minneapolis, USA) to block AMPA/kainate receptors were introduced to the standard ACSF.
-
bioRxiv - Neuroscience 2024Quote: ... IPSCs were recorded in the presence of 10µM CNQX (6-cyano-7-nitroquinoxaline-2,3-dione, Tocris 1045) and 50µM D-AP5 (D-2-amino-5-phosphonovalerate ...
-
bioRxiv - Neuroscience 2023Quote: The AMPA receptor antagonist cyanquixaline (6-cyano-7-nitroquinoxaline-2,3-dione; CNQX disodium salt; #1045; Tocris Biosciences) or 6,7-Dinitroquinoxaline-2,3(1H,4H)-dione (DNQX disodium salt ...
-
bioRxiv - Neuroscience 2024Quote: ... All networks received a 20-min 50 µM 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX, in DMSO; Tocris, #0373) treatment on top of that ...
-
bioRxiv - Bioengineering 2023Quote: ... was obtained through the administration of exponential doses with concentrations of 1 nM to 10 mM at 2 min intervals before the administration of 10 μM scopolamine (Tocris Bioscience Cat#1414/1G). After another equilibrium period ...
-
bioRxiv - Developmental Biology 2021Quote: ... which consists of a N2B27 basal medium supplemented with 3 µM CHIR99021 (Tocris), 1µM PD0325901 (SelleckChem ...
-
bioRxiv - Cancer Biology 2020Quote: ... established tumorspheres were treated with either 0.5 µM or 3 µM CHIR99021 (Tocris) for 5 days ...
-
bioRxiv - Neuroscience 2021Quote: ... The craniotomy was then covered with 3% agar (MilliporeSigma) dissolved in aCSF (TOCRIS). The agar was prevented from drying out by covering it with silicone oil ...
-
bioRxiv - Neuroscience 2021Quote: ... hiPSCs were pretreated for 5 days with 3 μM SB431542 (Tocris, Bristol, UK), 3 μM dorsomorphin (Sigma Aldrich) ...
-
bioRxiv - Neuroscience 2023Quote: ... The craniotomy was then covered with 3% agar (MilliporeSigma) dissolved in aCSF (TOCRIS). The agar was covered with silicone oil (60,000 centistokes ...
-
bioRxiv - Developmental Biology 2024Quote: ... This CBRa media consists of cSFDM containing 3 μm CHIR99021 (Tocris, No.4423), 10 ng/mL rhBMP4 (R&D ...
-
bioRxiv - Bioengineering 2023Quote: ... supplemented with Y-27632 (Tocris, cat# 1254, 5 µM, 24 h, day –3). On days 0 and 1 ...
-
bioRxiv - Neuroscience 2021Quote: ... 4- aminopyridine (Tocris Bioscience, 50 µM, 5 min-2hrs or 20hrs), AP5 (Tocris Bioscience ...
-
bioRxiv - Neuroscience 2020Quote: ... and the aquaporin-4 channel inhibitor TGN-020 (Tocris; 100 μM) were co-applied (n=16) ...
-
bioRxiv - Physiology 2021Quote: ... and/or 4) 100 nM ONO-8130 (Tocris Bioscience, Bristol, UK). In the latter two conditions ...
-
bioRxiv - Neuroscience 2023Quote: ... 50 µM CGP54626 Hydrochloride (1088/10, TOCRIS, CAS 149184-21-4), 200 µM (low dose ...
-
bioRxiv - Neuroscience 2019Quote: ... and NMDAR EPSCs were then isolated by addition of the AMPAR antagonist 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX, 10 µM; Tocris, Cat# 1044). NMDAR EPSCs were confirmed by addition of the NMDAR antagonist D,L-APV (20 µM ...
-
bioRxiv - Molecular Biology 2021Quote: ... culture medium was replaced by E6 medium supplemented with 6 μM CHIR (Tocris, Bio-Techne, Abingdon, United Kingdom) to initiate differentiation (defined as day 0) ...
-
bioRxiv - Neuroscience 2020Quote: ... to allow outside-out patch recording and 30 μM 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX; Tocris, Cat#1044) was added to media post-transfection to avoid AMPAR-mediated toxicity.